Oric Pharmaceuticals, Inc. Common Stock ORIC
i
Market datapartial · fetched 2026-11-12T00:45:00.342Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T21:00:00.205786736Z
FundamentalsAlpha Vantage · unavailable
Oric Pharmaceuticals, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 7.23 | 201.8% | 23.7% | |||
| 25Δ | 7.69 | 185.5% | 19.5% | |||
| 30Δ | 8.11 | 178.1% | 16.2% | |||
| 35Δ | 8.44 | 188.3% | 15.0% | |||
| 40Δ | 8.77 | 198.6% | 13.7% | |||
| 45Δ | ||||||
| 50Δ | ||||||
| 55Δ | ||||||
| 60Δ | ||||||
| 65Δ | 11.05 | 232.3% | 7.0% | |||
| 70Δ | 7.90 | 363.3% | 15.6% | 11.37 | 217.3% | 5.6% |
| 75Δ | 7.38 | 315.3% | 10.5% | 11.70 | 202.4% | 4.1% |
| 80Δ | 6.90 | 273.3% | 6.2% | 12.03 | 187.9% | 2.7% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 7.23
- IV
- 201.8%
- B/E move
- 23.7%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 7.69
- IV
- 185.5%
- B/E move
- 19.5%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 8.11
- IV
- 178.1%
- B/E move
- 16.2%
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 8.44
- IV
- 188.3%
- B/E move
- 15.0%
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 8.77
- IV
- 198.6%
- B/E move
- 13.7%
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
55Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 11.05
- IV
- 232.3%
- B/E move
- 7.0%
70Δ
- Pseudo strike
- 7.90
- IV
- 363.3%
- B/E move
- 15.6%
- Pseudo strike
- 11.37
- IV
- 217.3%
- B/E move
- 5.6%
75Δ
- Pseudo strike
- 7.38
- IV
- 315.3%
- B/E move
- 10.5%
- Pseudo strike
- 11.70
- IV
- 202.4%
- B/E move
- 4.1%
80Δ
- Pseudo strike
- 6.90
- IV
- 273.3%
- B/E move
- 6.2%
- Pseudo strike
- 12.03
- IV
- 187.9%
- B/E move
- 2.7%
Options history
Table
| Date | IV (%) |
|---|---|
| 181.71% | |
| 179.16% | |
| 171.61% | |
| 171.61% | |
| 176.42% | |
| 238.40% | |
| 255.65% | |
| 253.19% | |
| 240.65% | |
| 242.04% |
Biotechnology
ORKA
Oruka Therapeutics, Inc. is a biotechnology company.
More →ORMP
Oramed Pharmaceuticals Inc. is dedicated to the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or…
More →OTLK
Outlook Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. The company…
More →OVID
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medications for patients and families with neurological disorders in the United States. The company is…
More →PBLS
Parabilis Medicines, Inc. (Ticker: PBLS) is an emerging company at the forefront of the telecommunications sector, dedicated to delivering innovative communication solutions…
More →PBYI
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to improve cancer care in the United States and…
More →